石四药集团10月8日斥资572.66万港元回购200万股

Core Viewpoint - The company, 石四药集团 (Sihuan Pharmaceutical Holdings Group Ltd), announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1 - The company will spend HKD 5.7266 million to repurchase 2 million shares [1] - The buyback is scheduled for October 8, 2025, reflecting a strategic move to enhance shareholder value [1]